Embecta (EMBC) Non Operating Income (2021 - 2026)
Embecta (EMBC) reported Non Operating Income of -$22.6 million for Q1 2026, up 15.36% on a YoY basis from -$19.6 million in Q1 2025, and up 6.22% sequentially from -$24.1 million in Q4 2025.
Embecta (EMBC) Non Operating Income (2021 - 2026) Analysis & Trends
Embecta (EMBC) has 6 years of Non Operating Income data on file, last reported at -$22.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 15.36% year-over-year to -$22.6 million; the trailing twelve-month figure through Mar 2026 stood at $40.8 million (down 6.64% YoY), and the FY2025 full-year result was $1.5 million, up 114.56% from the prior year.
- Non Operating Income climbed to -$22.6 million in Q1 2026, from -$24.1 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $82.7 million in Q3 2025 to a low of -$27.7 million in Q4 2023.
- A 5-year average of $3.8 million and a median of -$2.7 million in 2022 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 2714.81% in 2023, while the deepest fall reached 4200.0% in 2023.
- Tracing EMBC's Non Operating Income over 5 years: stood at -$7.1 million in 2022, then slumped by 290.14% to -$27.7 million in 2023, then surged by 94.58% to -$1.5 million in 2024, then slumped by 1506.67% to -$24.1 million in 2025, then increased by 6.22% to -$22.6 million in 2026.
- Business Quant data shows EMBC's Non Operating Income at -$22.6 million in Q1 2026, -$24.1 million in Q4 2025, and $82.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 33,163,703.85 Bn | 33,163,702.19 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 119.67 Bn | 114.45 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Becton Dickinson | 43.92 Bn | 43.11 Bn | 2.15 Bn | - |
| 4 | Medline | 31.71 Bn | 29.47 Bn | 1.84 Bn | -131.00 Mn |
| 5 | Resmed | 28.46 Bn | 26.80 Bn | 890.98 Mn | 12.29 Mn |
| 6 | West Pharmaceutical Services | 23.80 Bn | 23.28 Bn | 296.40 Mn | -4.00 Mn |
| 7 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Solventum | 13.63 Bn | 13.06 Bn | 1.10 Bn | -62.00 Mn |
| 9 | Align Technology | 11.94 Bn | 10.88 Bn | 736.59 Mn | 6.93 Mn |
| 10 | Embecta | 195.69 Mn | 2.29 Mn | 127.80 Mn | -22.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.60 Mn |
| Dec 31, 2025 | -24.10 Mn |
| Sep 30, 2025 | 82.70 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | -26.70 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 73.00 Mn |
| Jun 30, 2024 | -1.10 Mn |
| Mar 31, 2024 | -1.50 Mn |
| Dec 31, 2023 | -27.70 Mn |
| Sep 30, 2023 | 70.60 Mn |
| Jun 30, 2023 | -27.00 Mn |
| Mar 31, 2023 | -4.30 Mn |
| Dec 31, 2022 | -7.10 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -19.50 Mn |
| Mar 31, 2022 | -100,000.00 |
| Sep 30, 2021 | -3.70 Mn |
| Jun 30, 2021 | 600,000.00 |
| Mar 31, 2021 | 2.10 Mn |